Does topical tranexamic acid reduce the need for nasal packing when initial epistaxis treatment has failed? This 2021 appraisal of the NoPAC trial examines its negative result, the importance of preceding first aid and vasoconstrictors, and limits to generalising across different types of bleeding.
Iain and Simon's January 2021 round-up brings together clinical evidence, education and staff wellbeing. The linked notes include Ludwig's angina, oxygen targets, moral injury, self-leadership and the evolving evidence on COVID-19 treatments and vaccines.
How do patients want clinicians to explain COVID-19 tests, uncertainty and the possibility of dying? In this February 2021 podcast, Rick Body speaks with patient representatives Graham Prestwich and Val Tate about communication through PPE and what matters to patients and families.
The first February 2021 report of RECOVERY's tocilizumab results, written as the announcement and preprint emerged. Simon Carley and Dan Horner outline the reported benefits in hospitalised patients with hypoxia and inflammation, while flagging the need for fuller appraisal and questions about immunosuppression.
What should emergency care performance measures tell us about patients' experience and safety? Craig Ferguson examines the standards proposed in England in 2021, the strengths and weaknesses of the four-hour target, and why changes to measurement need evidence as well as good intentions.
A 2021 appraisal of the Canadian TIA score's prospective validation and comparison with ABCD scores. It explores seven-day stroke risk, the need for validation in other settings and why better prediction only helps when local services can act on the result.